| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1021265713 |
| P356 | DOI | 10.1007/S11914-014-0235-Y |
| P932 | PMC publication ID | 4216598 |
| P698 | PubMed publication ID | 25200872 |
| P5875 | ResearchGate publication ID | 265474099 |
| P2093 | author name string | Emel Esen | |
| Fanxin Long | |||
| P2860 | cites work | The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes | Q22306221 |
| Stimulation of glucose transport in osteoblastic cells by parathyroid hormone and insulin-like growth factor I | Q24307296 | ||
| Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 | ||
| Strongly bound citrate stabilizes the apatite nanocrystals in bone | Q24618644 | ||
| Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition | Q24629773 | ||
| Aerobic glycolysis in bone: lactate production and gradients in calvaria | Q67260888 | ||
| Bone and mineral metabolism in BB rats with long-term diabetes. Decreased bone turnover and osteoporosis | Q68499371 | ||
| Zinc inhibition of mitochondrial aconitase and its importance in citrate metabolism of prostate epithelial cells | Q73853909 | ||
| Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation | Q73941872 | ||
| Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology | Q73958624 | ||
| Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women | Q74086478 | ||
| Evidence that anabolic effects of PTH on bone require IGF-I in growing mice | Q74532342 | ||
| Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization | Q74742272 | ||
| METABOLIC STUDIES OF BONE IN VITRO. V. GLUCOSE METABOLISM AND COLLAGEN BIOSYNTHESIS | Q76850434 | ||
| BONE CELLS: BIOCHEMICAL AND BIOLOGICAL STUDIES AFTER ENZYMATIC ISOLATION | Q76954538 | ||
| Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation | Q78680071 | ||
| Citric acid production by resorbing bone in tissue culture | Q78792148 | ||
| Metabolic studies of bone in vitro. I. Normal bone | Q79168139 | ||
| Metabolic studies of bone in vitro. II. The metabolic patterns of accretion and resorption | Q79168141 | ||
| The nature of bone citrate | Q79285462 | ||
| Aerobic metabolism of glucose by bone | Q79368424 | ||
| On the Origin of Cancer Cells | Q27861025 | ||
| Why do cancers have high aerobic glycolysis? | Q28290710 | ||
| Genetic regulation of osteoclast development and function | Q29617421 | ||
| Bioenergetics during calvarial osteoblast differentiation reflect strain differences in bone mass | Q30405481 | ||
| Loss of insulin receptor in osteoprogenitor cells impairs structural strength of bone. | Q33736279 | ||
| Up-regulation of glycolytic metabolism is required for HIF1α-driven bone formation | Q33767756 | ||
| Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism | Q34021680 | ||
| Conditional deletion of insulin-like growth factor-I in collagen type 1alpha2-expressing cells results in postnatal lethality and a dramatic reduction in bone accretion | Q34046618 | ||
| Structure and function of mammalian facilitative sugar transporters. | Q34061456 | ||
| Glucose-sensing mechanisms in eukaryotic cells. | Q34245438 | ||
| Overexpression of the ZIP1 zinc transporter induces an osteogenic phenotype in mesenchymal stem cells | Q34456539 | ||
| Distinct and overlapping functions of insulin and IGF-I receptors | Q34460872 | ||
| The biochemistry, metabolism and inherited defects of the pentose phosphate pathway: a review | Q34873925 | ||
| Oxidative stress, inflammation and carcinogenesis are controlled through the pentose phosphate pathway by transaldolase | Q35048149 | ||
| A Comprehensive Overview of Skeletal Phenotypes Associated with Alterations in Wnt/β-catenin Signaling in Humans and Mice | Q35755034 | ||
| Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells | Q36223256 | ||
| Osteocyte control of osteoclastogenesis | Q36514172 | ||
| The insulin-like growth factor system in bone: basic and clinical implications | Q36620533 | ||
| The Important Role of Osteoblasts and Citrate Production in Bone Formation: "Osteoblast Citration" as a New Concept for an Old Relationship | Q37274467 | ||
| Hexosamine flux, the O-GlcNAc modification, and the development of insulin resistance in adipocytes | Q37607447 | ||
| Building strong bones: molecular regulation of the osteoblast lineage | Q37970567 | ||
| Osteocyte regulation of phosphate homeostasis and bone mineralization underlies the pathophysiology of the heritable disorders of rickets and osteomalacia | Q38081019 | ||
| WNT-LRP5 signaling induces Warburg effect through mTORC2 activation during osteoblast differentiation. | Q39159584 | ||
| The influence of diabetes mellitus on the healing of closed fractures. | Q39647861 | ||
| Parathyroid Hormone Stimulation of Adenylate Cyclase Activity and Lactic Acid Accumulation in Calvaria of 4 Osteopetrotic (ia) Rats* | Q40209775 | ||
| Facilitative glucose transporters | Q40717146 | ||
| Effects of Diabetes Mellitus on Bone Mass in Juvenile and Adult-Onset Diabetes | Q41076132 | ||
| Dexamethasone modulates insulin receptor expression and subcellular distribution of the glucose transporter GLUT 1 in UMR 106-01, a clonal osteogenic sarcoma cell line. | Q41178555 | ||
| Methods for the separation of lactate dehydrogenases and clinical significance of the enzyme | Q41200983 | ||
| Expression and regulation by insulin of GLUT 3 in UMR 106-01, a clonal rat osteosarcoma cell line | Q41237063 | ||
| Aging impairs IGF-I receptor activation and induces skeletal resistance to IGF-I. | Q42512346 | ||
| Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone | Q42525601 | ||
| Citric acid and bone metabolism | Q42951839 | ||
| Zinc content of human cancellous bone | Q43983954 | ||
| The skeletal structure of insulin-like growth factor I-deficient mice | Q44588867 | ||
| The effects of local insulin delivery on diabetic fracture healing | Q46606728 | ||
| IGF-I receptor is required for the anabolic actions of parathyroid hormone on bone | Q46771350 | ||
| Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study | Q47742170 | ||
| Concentration of insulin-like growth factor (IGF)-I and -II in iliac crest bone matrix from pre- and postmenopausal women: relationship to age, menopause, bone turnover, bone volume, and circulating IGFs | Q47856406 | ||
| Osteopenia and male-specific sudden cardiac death in mice lacking a zinc transporter gene, Znt5. | Q54072702 | ||
| The osteoblast: an insulin target cell controlling glucose homeostasis. | Q54601524 | ||
| P433 | issue | 4 | |
| P921 | main subject | osteoblast | Q917177 |
| P304 | page(s) | 433-438 | |
| P577 | publication date | 2014-12-01 | |
| P1433 | published in | Current osteoporosis reports | Q26841869 |
| P1476 | title | Aerobic glycolysis in osteoblasts | |
| P478 | volume | 12 |
| Q39004609 | Bone-Derived Factors: A New Gateway to Regulate Glycemia |
| Q101226611 | Emerging insights into the comparative effectiveness of anabolic therapies for osteoporosis |
| Q38948993 | Emerging role of metabolic signaling in synovial joint remodeling and osteoarthritis |
| Q50439652 | Energy Metabolism of the Osteoblast: Implications for Osteoporosis |
| Q42001274 | Fatty acid metabolism by the osteoblast. |
| Q50428854 | Glucose metabolism in bone. |
| Q59128918 | Glucose metabolism induced by Bmp signaling is essential for murine skeletal development |
| Q92628971 | Increased glycolysis mediates Wnt7b-induced bone formation |
| Q38771246 | Mechanisms of marrow adiposity and its implications for skeletal health |
| Q64972879 | MicroRNA-181a/b-1 over-expression enhances osteogenesis by modulating PTEN/PI3K/AKT signaling and mitochondrial metabolism. |
| Q37101382 | Navigating the bone marrow niche: translational insights and cancer-driven dysfunction. |
| Q48531624 | Nε-carboxymethyl-lysine promotes calcium deposition in VSMCs via intracellular oxidative stress-induced PDK4 activation and alters glucose metabolism |
| Q36779829 | PTH Promotes Bone Anabolism by Stimulating Aerobic Glycolysis via IGF Signaling |
| Q36775909 | Parathyroid Hormone Reprograms Osteoblast Metabolism |
| Q89783003 | Preparation and Characterization of Self-Assembled Poly(l-Lactide) on the Surface of β-Tricalcium Diphosphate(V) for Bone Tissue Theranostics |
| Q37587657 | Protein/amino-acid modulation of bone cell function |
| Q38577490 | The past 10 years-new hormones, new functions, new endocrine organs |
| Q92136364 | Wnt Antagonists in Hematopoietic and Immune Cell Fate: Implications for Osteoporosis Therapies |
| Q39020338 | Wnt signaling and cellular metabolism in osteoblasts |
Search more.